In an interview with Ophthalmology Times, clinical trial investigator Zaina Al-Mohtaseb MD, noted the CLARA Phase 1/2 trial demonstrated the safety, efficacy, and simplicity of corneal endothelial ...

Clinical Data from First Subject Dosed Twice Daily with QRX003 in Open Label Study Is Positive at Mid-point of ...

The study is one of five clinical efforts - three proof-of-concept investigator-initiated trials (IIT) and two Phase 2 studies - of crofelemer ...

New documents have investigators questioning inconsistencies and omissions in data reporting in the PLATO trial, building on ...

A machine learning tool incorporating both clinical and genomic data helps predict response to CDK4/6 inhibitor therapy in ...

Regulatory Approval Showcases Clinical Advancement of Linea DNA™ as a Rapid and Effective Means of Producing CAR-T cell ...

Huntsman Cancer Institute at the University of Utah (the U) has joined other institutions in an innovative clinical trials ...

Objective clinical responses by standard response criteria observed in Phase 1 dose escalation trial for FHD-286 in combination with decitabine in patients with relapsed and/or refractory AML; ...

Harvest Integrated Research Organization HiRO a boutique global clinical research organizationCRO providing cross-border ...

UB researchers find that feedback from Community Engagement Studio sessions can have a major impact on their studies.

Neuralink owner Elon Musk shared a letter from his lawyer on the social media platform X detailing an “improperly motivated ...

The U.S. Food and Drug Administration has approved Galderma's Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older.